| Tara Sharifan, PSYD | |
|
505 S Main St Ste 209, Bountiful, UT 84010-6398 | |
| (385) 244-0055 | |
| Not Available |
| Full Name | Tara Sharifan |
|---|---|
| Gender | Female |
| Speciality | Psychologist - Clinical Child & Adolescent |
| Location | 505 S Main St Ste 209, Bountiful, Utah |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356620264 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC2200X | Psychologist - Clinical Child & Adolescent | 10476501-2501 (Utah) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Tara Sharifan, PSYD 171 Gary Way, North Salt Lake, UT 84054-1534 Ph: () - | Tara Sharifan, PSYD 505 S Main St Ste 209, Bountiful, UT 84010-6398 Ph: (385) 244-0055 |
News Archive
Pursuant to the provisions of Section 7 paragraph 1(a) of the Dutch Decree on Public Takeover Bids (Besluit Openbare Biedingen Wft) requiring a public announcement within four weeks following the announcement of an intended public offer to provide a status update, Johnson & Johnson (NYSE: JNJ) and Crucell N.V. provide the following joint update.
As part of MIT's continued mission to help build a better world, the Institute announced the creation of the Alana Down Syndrome Center, an innovative new research endeavor, technology development initiative, and fellowship program launched with a $28.6 million gift from Alana Foundation, a nonprofit organization started by Ana Lucia Villela of São Paulo, Brazil.
Synageva BioPharma Corp., a privately held biopharmaceutical company developing therapeutic products for rare disorders, announced today that their lead program, SBC-102, an enzyme replacement therapy for Lysosomal Acid Lipase (LAL) Deficiency, currently in clinical trials, has been granted fast track designation by the U.S. Food and Drug Administration (FDA).
The new data show that the number of adolescents ages 12 to 17 admitted to substance abuse treatment increased 65 percent between 1992 and 2002. In 1992, adolescents represented 6 percent of all treatment admissions.
Ground-breaking new Danish research has shown that the current scientific description of the human cell cycle needs to be revised. These findings could also lead to the development of new therapeutic approaches to target an Achilles' heel in different types of cancers.
› Verified 3 days ago
Dr. Donald Randall, PHD Psychologist Medicare: Accepting Medicare Assignments Practice Location: 630 Medical Dr, Bountiful, UT 84010 Phone: 801-299-2186 | |
Lyndsey Evans, Psychologist Medicare: Medicare Enrolled Practice Location: 415 Medical Dr Ste D101, Bountiful, UT 84010 Phone: 801-683-1062 Fax: 801-295-5537 | |
Dr. Eden Deanne Steffey, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 415 Medical Dr Ste D101, Bountiful, UT 84010 Phone: 801-683-1062 Fax: 801-295-5537 | |
Dr. Jerry Lynn Sandberg, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1470 N Main St Ste B, Bountiful, UT 84010 Phone: 801-299-9026 Fax: 801-299-9026 | |
Fred Brooks, M.ED; ED.S Psychologist Medicare: Not Enrolled in Medicare Practice Location: 415 Medical Dr Ste D101, Bountiful, UT 84010 Phone: 801-683-1062 Fax: 801-295-5537 | |
Quincey Lee Atkin, PHD Psychologist Medicare: Accepting Medicare Assignments Practice Location: 390 N Main St, Bountiful, UT 84010 Phone: 801-294-1000 Fax: 801-292-8369 |